AXIN2 and prostate carcinoma: To further confirm that XHP participates in the mechanism of prostate cancer cell proliferation by modulating Wnt signaling, XAV-939 (a Wnt signaling inhibitor that functions by stabilizing Axin2) was used as a positive control drug [18].